Mission

Virometix' mission is the development of safe and effective new-generation vaccines for the treatment of chronic human diseases and the prevention of infectious diseases afflicting millions of people worldwide.

Virometix exploits the tools traditionally used in drug discovery – rational molecular design and chemical synthesis – for the generation of structurally optimized synthetic antigen mimetics and its proprietary Synthetic Virus-Like Particle platform technology for delivery of the synthetic antigen mimetics to cells of the immune system.